Terumo Invests £33 Million Into Vascutek Expansion


February 12, 2018—Terumo Corporation has announced a £33 million investment into subsidiary Vascutek Ltd. with a goal of driving further growth for the Scotland-based vascular graft manufacturer.

The investment will support expanding Vascutek's headquarters and manufacturing facilities, including the addition of two new cleanrooms and a sterilization suite. Vascutek primarily manufactures devices aimed at treating aortic disease pathologies, such as the Anaconda, Anaconda Fenestrated, and the Thoraflex Hybrid platforms.

The Tokyo-based Terumo acquired Vascutek in 2002 and added Bolton Medical in 2017.

The expansion is scheduled to begin in April 2018 and be complete in 2021.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.